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Introduction: The emotional burden associated with the diagnosis of cancer is sometimes overshadowed by
financial burden sustained by patient and the family. This is especially relevant for a developing country as there is
limited state support for cancer treatment. We conducted this study to estimate the cost of cancer care for two
major types of cancer and to assess the perception of patients and families regarding the burden of the cost for
undergoing cancer treatment at a private tertiary care hospital.
Methods: This cross-sectional study was conducted at day care and radiotherapy unit of Aga Khan University,
Hospital (AKUH) Karachi, Pakistan. All adult patients with breast and head & neck cancers diagnosed for 3 months
or more were included. Data was collected using a structured questionnaire and analysed using SPSS.
Results: Sixty seven patients were interviewed during the study period. The mean and median monthly income of
these patients was 996.4 USD and 562.5 USD respectively. Comparatively the mean and median monthly cost of
cancer care was 1093.13 USD and 946.42 USD respectively. The cost of the treatment either fully or partially was
borne by the family in most cases (94%). The financial burden of cancer was perceived as significant by 28 (42%)
patients and unmanageable by 18 (27%) patients. This perceived level of burden was associated significantly with
average monthly income (p = <0.001).
Conclusion: Our study indicates that the financial burden of cancer care is substantial and can be overwhelming.
There is a desperate need for treatment support programs either by the government or other welfare organisations
to support individuals and families who are already facing a difficult and challenging situation.
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The diagnosis of cancer is shocking news for any indi-
vidual and his/or her family. Cancer is a chronic disease
and the physical and emotional burden can sometimes
be overshadowed by the financial burden incurred by
the family. In developed countries and more affluent so-
cieties of the world, a large part of this burden is shared
by the state. But even so, studies from the developed
countries like Canada [1] have shown that patients and
families experience significant burden despite several
state plans that are in place to address the issue. Wage* Correspondence: drtayyaba@gmail.com
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reproduction in any medium, provided the orlosses due to cancer treatment in working women with
breast cancer adversely affect the barely manageable
situation and add to the financial burden sustained by
the patient [2]. Another study from the USA showed
that financial burden can be substantial even among
women with comprehensive health insurance policies
[3]. Similarly, a study from Australia publicised that lost
income, health service expenditures and lost unpaid
work were the greatest sources of economic burden
among women with breast cancer [4].
In Pakistan, like many other developing countries,
there is little assistance from the government and in
many cases the entire costs, including direct and indirect
costs, are borne by the patient and his or her family. To
our knowledge there has been no study conducted ind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of patients undergoing breast and





Male (n=23) Female (n=44)
Age Groups
25-45 years 12 22
≥46-60 years 11 22
Mean age(years) 42.6 46.8
Residence
Karachi 53 (79) 16 37
Outside Karachi 14 (21) 7 7
Type of cancer
Breast 40 (59.7 ) 0 40
Head and Neck 27 (40.3 ) 23 4
Patient bread earner before diagnosis
Yes 26 (38.8 ) 21 5
No 41 (61.2 ) 2 39
Cost borne by patient or family
Completely/Partially 63 (94 ) 21 42
Third party support 4 (6 ) 2 2
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very limited data from other developing countries facing
a similar situation. Therefore, we conducted this study
to estimate the cost of cancer care for two major types
of cancers at Aga Khan University Hospital (AKUH).
This is a private university hospital in Karachi that offers
comprehensive cancer care. We also assessed the per-
ceived financial burden of cancer care among patients
and their care givers.
Methods
This cross-sectional study was conducted at Aga Khan
University, Hospital (AKUH) Karachi Pakistan from
March 2009 to March 2010. All adult patients who had
been diagnosed with either breast or head & neck can-
cers for at least three months were included in the study.
Patients were enrolled from the Day-care chemotherapy
and radiation therapy units. Interviews were conducted
from the patients and/or family members and data was
collected using a structured pre-tested questionnaire.
Interviews were conducted by a medical student after
initial pilot testing. Questions included demographics,
family income, treatment costs, insight regarding the
treatment and expectations of the patients and families.
Complete confidentiality of the information collected
was ensured. No personal data was collected by which
the participants could be identified afterwards. Written
consent was taken from all participants. The study was
approved by the Aga Khan University’s Ethical Review
committee.
Statistical analysis
Data was analysed using commercially available software
package for social science SPSS version 17. All costs
were estimated as Rupees per month and later converted
into dollars for analysis. The conversion rate of 2009-
2010 was used and applied to other studies for compari-
son. Descriptive analysis was carried out for patients’
demographics and clinical characteristics. Means with
standard deviations were calculated for continuous vari-
ables and proportions were calculated for categorical
variables. Chi-square test was used for Univariate ana-
lysis for significance of categorical variables in determin-
ing perceived level of burden and cost anticipation of
the treatment. Logistic regression was done for same
categorical variables in multivariate analysis. The signifi-
cance level was set at 5%. Student’s t-test was applied for
multiple values of test variables.
Results
In all, 67 patients were interviewed. Of these 44 (66%)
were females and 23 (34%) were males. The mean age of
males and females was 42.6 and 46.8 years respectively.
The majority of the responders were from Karachi(79%). The distribution of the type of cancer shows
marked variation between genders as most females had
breast cancer (91%) and all males had head and neck
cancer (100%). Overall 66 patients gave information
about their total monthly income. The mean and median
monthly family income of these patients was 996.4 USD
and 562.5 USD respectively. Comparatively, the mean
and median monthly cost of cancer care was 1093.13
USD and 946.42 USD respectively. The patient was the
primary bread earner in 38.8% of the cases. The charac-
teristics of the patients are shown in Table 1.
The overall average duration of the treatment was 6.7
months, that for breast cancer was 7.8 months and for
head and neck cancer was 5.04 months. The cost of the
treatment was either fully or partially borne by the pa-
tient or the family in 94% of the cases.
Regarding cost anticipation, 20 (29.9%) patients con-
firmed that the costs were ‘more’ than anticipated or
presumed, 29 (43.3%) responded that they were ‘much
more’ than anticipated while for 18 (26.9%) patients the
costs were ‘not’ more than anticipated. Less than half
(44.8%) of the total patients (30 out of 67) informed that
they were aware of the cost at the start of the treatment.
The association between cost awareness and cost antici-
pation was statistically significant (p=0.01). The univari-
ate and multivariate analyses for cost anticipation is
shown in Table 2.
The burden of cancer was perceived as significant by
28 (42%) patients and unmanageable by 18 (27%)
patients. Those who had monthly income less than 250












n (%) n (%) p p
Gender
Male 19(83) 4(17) 0.26 0.43
Female 30(68) 14(32)
Age Groups 0.41 0.43
25-45 years 23(68) 11(32)
≥46-60 years 26(79) 7(21)
Awareness of cost at outset
Yes 17(57) 13(43) 0.01 0.03
No 32(86) 5(14)
Type of cancer
Breast 28(70) 12(30) 0.58 0.62
Head and neck 21(78) 6(22)
Current residence
Karachi 39(74) 14(26) 1.0 0.79
Outside Karachi 10(71) 4(29)
Income groups




< 60,000 17(74) 6(26) 0.95 0.35
60,000-100000 17(71) 7(29)
>100,000 15(75) 5(25)
Table 4 Univariate and multivariate Analysis for
Perceived level of burden







n (%) n (%) p p
Gender
Male 5(22) 18(78) 0.26 0.99
Female 16(36) 28(64)
Age Groups
25-45 years 12(35) 22(65) 0.60 0.15
≥46-60 years 9(27) 24(73)
Awareness of cost at outset
Yes 11(37) 19(63) 0.44 0.64
No 10(27) 27(73)
Type of cancer





Karachi 16(30) 37(70) 0.75 0.33
Outside Karachi 5(36) 9(64)
Income groups




< 60,000 4(17) 19(83) 0.10 0.09
60,000-100000 9(38) 15(62)
>100,000 8(40) 12(60)
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cant or unmanageable (95%) as compared to those who
had monthly income more than 625 USD (37.5%) i.e.
95% of the people who had monthly income less than
250 dollars (20 out of 21) perceive the cost of the treat-
ment as significant or unimaginable as opposed to 37.5%
of responders (9 out of 24) who have monthly income
more than 625 USD. The details of the income groups
and their perceived level of burden are shown in
Table 3.Table 3 Perceived level of financial burden by income among




None Slight Some-what Significant
<=250 1 0 0 7
251-625 2 2 0 12
>625 6 5 4 9
Missing* 1
Total 9 8 4 28
* One patient did not give information about monthly income.The association was not statistically significant between
perceived level of burden and the type of cancer
(p=0.79), gender (p=0.26), average monthly cost of treat-
ment (p=0.10) or the area of residence (p=0.75). How-
ever, the association was statistically significant with the
monthly income (p=<0.001). Also in multivariate analysis
the monthly income was the only variable that showed
significant association with the perceived level of burden
(p=0.009). The monthly cost of the treatment barelypatients undergoing breast and head and neck cancer
ived level of Burden(n)
Un-manageable % age of perceived burden as significant &






Table 6 Percent of different types of costs
Type of Expenses Mean With (±SD) Median




Chemotherapy 32.82 (±18.04) 32.00
Radiotherapy 21.41 (±11.17) 20.08
Other 8.88 (±8.01) 5.92
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variate and multivariate analysis for perceived level of
burden is shown in Table 4.
The monthly income and the monthly cost of treat-
ment showed a trend towards association but that was
not statistically significant (p=0.072). Those who had
monthly income less than 250 USD were more likely to
have monthly cost of treatment less than 750 USD
(52.38%) as compared to those who had monthly income
more than 625 USD (16.67%) as shown in Table 5.
The association between monthly cost of treatment
and months into treatment was not significant
(p=0.116), although the mean monthly cost of treatment
was much higher for those who were less than 6 months
into treatment as compared to those who were more
than 9 months into treatment (Table 5).
Percentages of different of types of costs are shown in
Table 6. Hospitalization, surgery and investigations
accounted for most of the costs with mean and median
percentage of 43.40 and 42.97 respectively. Doctor’s fee
accounted for a mean of 7.48% and median of 5.76% of
the total cost of treatment. The cost of chemotherapy
and radiotherapy were quite variable and could be as
high as 78.33% and 45.71% respectively in some cases.
The total costs were underestimated in our study by
patients on account of on-going treatments.Discussion
Though our study targeted a selected patients’ group
from a single centre, yet it points out that the stigma
of the financial burden of the cancer care could be
substantial and overwhelming. The financial problems
and social complexities could multiply the stress and
the sufferings associated with the disease itself and the
toxicities of the treatment manifolds.Table 5 Monthly cost of cancer care by income (p=0.072) and













* One patient did not give information about monthly income.The financial aspect of the disease is particularly sensi-
tive in countries like Pakistan where almost entire cost
of the treatment is borne by the patient and the immedi-
ate family with little or no support from state or health
insurance policies. Hence, the diagnosis of the cancer
could be devastating news not only because of nature of
the disease but also because of the continuous financial
drain posed by the costs of the treatment.
According to IMF as of 2010 [5], Pakistan’s Gross do-
mestic product (GDP) per capita stands at 1,067.971 US
dollars while Gross domestic product (GDP) based on
purchasing power parity (PPP) per capita stands at
2,713.272 US dollars. The average family income is
226.10USD/month but Pakistan is a country of extremes.
According to human development report 2008 [6],
60.3% of Pakistani population has daily income of 2 US
dollars or less. However, our study group represented a
relatively more affluent section of the society with a me-
dian family income of 996.4 USD per month. Despite
this, the monthly cost of treatment i.e.1093.13 USD, far
exceeded the average monthly income of the entire ‘af-
fluent’ family (996.4 USD). This could mean utilisation
of savings and other means to bridge the deficit. In the
worst scenario, this might lead to falling in debt which
had been reported by 34.3% of the patients. It could be
inferred from the above fact that some people frommonths into treatment (p=0.116) among patients
Monthly cost in USD
>1250 Mean (±SD) Total (n)
4 895.53 (±518.50) 21
4 960.86 (±374.76) 21
11 1344.50 (±579.21) 24
1 1
20 67
13 1263.76 (±514.61) 29
6 1005.94 (±563.74) 27
1 857.31 (±454.58) 11
20 1093.13 (±542.24) 67
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cumbed to the disease without getting treatment due to
the affordability issue. Nevertheless, this needs to be
documented from public sector before drawing a con-
clusion from the assumption.
Majority of the patients in our study (73%) reported that
the costs were either more or much more than anticipated
and 55.2% of the study subjects stated that they were not
aware of the cost of treatment at outset. The cost of the
treatment was underestimated by mostly those people
who were oblivious of the cost from the outset. This was
again not surprising as a cost related to cancer care is not
a one-time expense in most cases. This is different from a
one-time expense like knee replacement etc.
In Pakistan, families still rely overwhelmingly on an in-
come of single earning member. This is usually the male
member of the house. In our study all the patients with
breast cancers were females and majority of them were
homemakers with little income of their own. They were
completely dependent on their families for the treatment
expenses. The situation was even worse for the male
patients, as they were the bread earners for their families
in 91% of the cases. It gets almost impossible to sustain
that supporting position when cancer treatment is
underway for the main earning member. The emotional
and physical toll could be even more difficult when the
prognosis is poor.
This is in contrast to the findings in the western coun-
tries where the hospital related costs are mostly covered
by the state or insurance policies. The financial burden
in the west is mostly associated with lost income etc.
Therefore, studies from that part of the world usually
address the non-treatment related financial burden. A
study conducted in USA in privately insured women
with breast cancer reported average monthly financial
burden of $1, 455 [3] but the GDP of USA based on pur-
chasing power parity (PPP) per capita is 47,701.80 USD
[7].. Nevertheless,, a study carried out in USA showed
that despite comprehensive health insurance policies fi-
nancial burden of breast cancer can be substantial [3].
Another study carried out in Canada showed that des-
pite the fact that treatment and hospital related costs areTable 7 Comparison of the overall cost from an international
Studies Monthly income USD Monthly Cost
Mean USD (SD)
Our study < 250 (32%) 1028 (510)
251-625 (32%)
>625 (36%)
Arozullah et al [3] < 2500 (19%) 1455 (2366)
2500-5000 (27%)
>5000 (54%)paid by the public health care system, patients with
breast cancer face financial hardship and numerous
other costs posing a significant financial burden. The
costs are especially worrisome when the financial means
to cover them are inadequate [8]. It would be difficult to
imagine the perceived financial burden if the entire
treatment costs are shifted onto the patient and family
as is the case in Pakistan. The word significant and sub-
stantial has been used in these studies from the litera-
ture but percentage reporting this has been described in
a different format which limited the direct comparison
between developing and developed countries. Also most
of the studies have addressed the out of pocket and in-
direct cost from patients’ perspective. The cost figures
from a similar study have been shown in Table 7. We
could appreciate the comparable figures of mean cost of
the treatment between our study and study by Azorullah
et al [3] but there is a huge variation in the monthly
income which could multiply the perceived level of
burden by many folds.
In most low income countries, people have to rely on
themselves and do not necessarily look out to the gov-
ernment for health care needs.
The cost of the treatment is of prime importance while
making treatment decisions and sometimes governs the
choice of the treatment selected for a particular patient.
This was reflected in an interesting trend in our study
where patients with low monthly income had less
monthly cost of treatment as compared to those with
high monthly income. Although this did not reach statis-
tical significance, but physicians working in Pakistan
could appreciate this fact where many times a treatment
is tailored to the financial situation of the patient. Simi-
lar finding has been reported from a study in USA,
which showed that families with the lowest household
income had least expenses. However the proportion of
household income spent on cancer care was higher for
low income families [3].
The small sample size was a major limitation in our
study. Many patients refused to consent for disclosure of
details regarding the income due to sensitivity of the
issue. Day care and radiotherapy unit of AKUH renderStudy
Cost from time since treatment Mean USD (SD)
<6months 6-12 months >12 months
1189 (484) 920 (500) 846 (540)
1375 (2157) 2331 (3424) 669 (634)
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Karachi city [9] and also receive referrals from all over
the country. The patient group is diverse comprising of
all ages with different malignant disorders i.e. solid
tumours and lymphomas. We had targeted select types
of cancers, thus, done a purposive sampling for the sake
of simplicity as this was the first study of its kind from
Pakistan. The age and gender distribution was a bit
skewed for the very same reason. This has limited the
generalisation of the results, but this could be consid-
ered a pilot study with more comprehensive studies to
follow. Nevertheless, it has given an insight regarding
the under-addressed prevailing issue.
Conclusion
Our study indicated that the financial burden of cancer
care was substantial and mostly borne by the patient or
the family. Most of the time, the monthly average cost of
the treatment far exceeded the monthly household in-
come and a significant proportion of patients perceived
the financial burden as overwhelming. There should be
financial support programs on part of the government
and other organisations to cover up for the treatment
costs of the cancer and to help these patients in man-
aging the already difficult and challenging situation.
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